Apo-Mometasone Dosage/Direction for Use

Treatment of seasonal or perennial allergic rhinitis: Adults (including the elderly) and children 12 years of age and older: The usual recommended dose is two sprays (50 micrograms/spray) into each nostril once daily (total dose 200 micrograms). Once symptoms are controlled, dose reduction to one spray into each nostril (total dose 100 micrograms) may be effective for maintenance.
Children between the ages of 3 and 11 years: The usual recommended dose is one spray (50 micrograms/spray) into each nostril once daily (total dose 100 micrograms).
Administration to young children should be aided by an adult when using Apo-Mometasone Aqueous Nasal Spray.
Clinically significant onset of action occurs as early as 12 hours after the first dose.
Nasal Polyposis: Adults (including the elderly) and adolescents 18 years of age and older: The usual recommended dose for polyposis is two sprays (50 micrograms/spray) in each nostril once daily (total daily dose of 200 mcg). If symptoms are inadequately controlled, the dose may be increased to a daily dose of two sprays in each nostril twice daily (total daily dose of 400 mcg). Dose reduction is recommended following control of symptoms.
Treatment of mild to moderate uncomplicated acute rhinosinusitis: Adults (including the elderly) and children 12 years of age and older: The usual recommended dose is two sprays (50 micrograms/spray) into each nostril twice daily (total daily dose of 400 mcg). If no improvement is seen after 15 days of twice daily administration, alternative therapies should be considered. If symptoms worsen during treatment, the patients should be advised to consult their physician.